SCHEMBL21626593

SCHEMBL21626593

Cc1ccc(S(=O)(=O)n2cc(C3CC3)c3c(Oc4ccc(CC(NC(=O)OC(C)(C)C)C(=O)O)cc4F)ccnc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN1 P18031 1/20 0.38
KLK7 P49862 1/20 0.37
ALDH1A1 P00352 2/20 0.36
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
TSHR P16473 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
ITGA4 P13612 3/20 0.34
ITGB7 P26010 2/20 0.34
ACE P12821 1/20 0.34
MAPK1 P28482 1/20 0.33
BCL2 P10415 1/20 0.33
P2RX7 Q99572 2/20 0.33
MET P08581 1/20 0.33
ALOX5 P09917 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21626592 1.00 MEN1 (0.39) MEN1POLBKMT2APTPN1KLK7
SCHEMBL21626600 0.94 MEN1 (0.35) MEN1POLBKMT2APTPN1KLK7
SCHEMBL21626599 0.94 MEN1 (0.35) MEN1POLBKMT2APTPN1KLK7
SCHEMBL20437153 0.91 MEN1 (0.42) MEN1POLBKMT2APTPN1KLK7
SCHEMBL28562102 0.90 PTPN1 (0.41) MEN1KMT2APTPN1ITGB3ITGA2B
SCHEMBL23813319 0.90 KMT2A (0.40) MEN1POLBKMT2AKLK7ALDH1A1
SCHEMBL23799253 0.89 MEN1 (0.41) MEN1POLBKMT2APTPN1KLK7
SCHEMBL23799254 0.89 MEN1 (0.41) MEN1POLBKMT2APTPN1KLK7
SCHEMBL28562103 0.88 PTPN1 (0.42) MEN1KMT2APTPN1ACEMAPK1
SCHEMBL20437151 0.85 MEN1 (0.37) MEN1POLBKMT2APTPN1KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284639-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-09-16 US disclosed
WO-2020016129-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2020-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284639-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS ROCK1, ROCK2, CIT MEN1 4507/4885POLB 2768/4885KMT2A 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.